glp 1 drug novo nordisk Ro Launches Wegovy® Pill Through Integration with GLP-1 obesity drugs cleared of

In people with type 2 diabetes who also use insulin or insulin-stimulating drugs, such as sulfonylureas, the risk of low blood sugar, also called hypoglycemia, may be increased, so the doses of those medicines may need to be lowered

Documented monitoring consideration: because new or darkening pigmented lesions are a documented effect (Minder et al., 2013), dermatology literature describes baseline and periodic skin checks for those on melanocortin agonists

Risks of Microdosing GLP-1s While the concept of microdosing may seem appealing, it comes with risks

Diarrhea may be worse in people taking metformin, especially with omeprazole, and in some cases lowering the metformin dose can help